Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-3.57 Insider Own55.28% Shs Outstand40.86M Perf Week-9.39%
Market Cap399.06M Forward P/E- EPS next Y-3.30 Insider Trans-0.05% Shs Float22.28M Perf Month10.64%
Income-146.04M PEG- EPS next Q-0.84 Inst Own43.72% Short Float / Ratio17.52% / 3.05 Perf Quarter77.21%
Sales0.00M P/S- EPS this Y-13.57% Inst Trans1.08% Short Interest3.90M Perf Half Y-3.73%
Book/sh4.10 P/B1.95 EPS next Y4.11% ROA-54.31% Target Price15.25 Perf Year-27.84%
Cash/sh3.81 P/C2.10 EPS next 5Y- ROE-64.09% 52W Range3.94 - 12.33 Perf YTD-28.93%
Dividend- P/FCF- EPS past 5Y-58.82% ROI-79.82% 52W High-35.04% Beta1.39
Dividend %- Quick Ratio5.66 Sales past 5Y-10.83% Gross Margin- 52W Low103.52% ATR0.77
Employees58 Current Ratio5.66 Sales Q/Q- Oper. Margin0.00% RSI (14)46.60 Volatility9.12% 9.50%
OptionableYes Debt/Eq0.09 EPS Q/Q-42.96% Profit Margin- Rel Volume0.26 Prev Close7.84
ShortableYes LT Debt/Eq0.08 EarningsNov 13 AMC Payout- Avg Volume1.28M Price8.01
Recom1.29 SMA20-8.06% SMA504.58% SMA20024.80% Volume333,945 Change2.17%
Date Action Analyst Rating Change Price Target Change
Dec-22-21Downgrade Jefferies Buy → Hold $65 → $25
Sep-30-21Initiated Stifel Buy $106
May-05-21Resumed Credit Suisse Outperform $98
Apr-26-21Resumed Credit Suisse Outperform $98
Apr-06-21Initiated UBS Buy
Feb-10-21Initiated H.C. Wainwright Buy $100
Aug-11-20Initiated Piper Sandler Overweight $55
Aug-11-20Initiated Jefferies Buy $50
Aug-11-20Initiated Credit Suisse Outperform $53
Aug-11-20Initiated Cantor Fitzgerald Overweight $64
Nov-13-23 04:47PM
Nov-01-23 04:05PM
Oct-10-23 04:05PM
Oct-06-23 04:59AM
10:58AM Loading…
Oct-05-23 10:58AM
Oct-04-23 04:10PM
Oct-03-23 11:15AM
Oct-02-23 04:05PM
Sep-06-23 08:00AM
Aug-31-23 07:00AM
07:31PM Loading…
Aug-14-23 07:31PM
Aug-10-23 04:01PM
Jun-26-23 07:00AM
May-11-23 04:01PM
May-09-23 07:00AM
Apr-25-23 07:00AM
Apr-19-23 11:36AM
Mar-14-23 08:00AM
Mar-13-23 07:00AM
Mar-09-23 04:01PM
Feb-16-23 07:00AM
Jan-05-23 07:00AM
Jan-03-23 07:00AM
Dec-12-22 10:00AM
07:00AM Loading…
Nov-29-22 07:00AM
Nov-08-22 04:01PM
Nov-03-22 09:00AM
Nov-02-22 07:00AM
Oct-31-22 07:00AM
Oct-05-22 08:01AM
Sep-21-22 04:01PM
Sep-01-22 07:00AM
Aug-16-22 09:45AM
Aug-15-22 07:00AM
Aug-11-22 07:00AM
Aug-08-22 04:01PM
Aug-01-22 07:00AM
Jun-29-22 08:44AM
Jun-22-22 09:00AM
Jun-03-22 07:00AM
Jun-01-22 07:00AM
Apr-12-22 07:00AM
Mar-02-22 07:00AM
Feb-28-22 07:00AM
Feb-03-22 07:01PM
Feb-02-22 01:38PM
Jan-28-22 12:44PM
Jan-27-22 05:51PM
Jan-19-22 06:23AM
Jan-10-22 06:00AM
Jan-04-22 07:00AM
Dec-14-21 09:00AM
Dec-13-21 01:58PM
Dec-12-21 09:00AM
Nov-11-21 04:05PM
Nov-09-21 11:13AM
Nov-04-21 09:00AM
Nov-02-21 09:00AM
Oct-21-21 11:19AM
Oct-07-21 07:00AM
Oct-01-21 08:00AM
Sep-16-21 07:00AM
Sep-14-21 07:00AM
Sep-07-21 07:00AM
Aug-27-21 06:55AM
Aug-12-21 04:05PM
Jul-28-21 07:00AM
Jul-15-21 12:00PM
Jul-12-21 06:07AM
Jul-06-21 09:15AM
Jul-03-21 07:15AM
Jun-14-21 07:00AM
Jun-10-21 07:00AM
May-18-21 07:00AM
May-17-21 04:05PM
May-10-21 07:00AM
Apr-21-21 04:05PM
Apr-16-21 01:41AM
Apr-05-21 07:00AM
Mar-18-21 04:05PM
Mar-15-21 07:00AM
Mar-05-21 08:15AM
Mar-04-21 04:05PM
Mar-03-21 08:34AM
Mar-02-21 07:00AM
Feb-10-21 10:05AM
Jan-16-21 01:12AM
Jan-11-21 07:00AM
Jan-05-21 07:00AM
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pinto ShellyVP, Finance and CAOJul 06Sale6.527,34547,88955,713Jul 07 04:09 PM
Pons JaumePresident & CEOJun 30Sale7.343,20823,547536,538Jul 05 05:07 PM
Randolph SophiaChief Medical OfficerJun 30Sale7.341,60511,781281,477Jul 05 05:09 PM
GARCIA PETER SChief Financial OfficerJun 30Sale7.348876,51154,738Jul 05 05:00 PM
Pinto ShellyVP, Finance and CAOJun 30Sale7.344663,42063,058Jul 05 05:05 PM
Randolph SophiaChief Medical OfficerJun 09Option Exercise3.7512,82948,171283,082Jun 13 04:38 PM
Pons JaumePresident & CEODec 29Sale11.073,23235,779539,746Jan 03 08:29 PM
Randolph SophiaChief Medical OfficerDec 29Sale11.071,61717,901270,253Jan 03 08:47 PM
GARCIA PETER SChief Financial OfficerDec 29Sale11.078939,88653,723Jan 03 08:34 PM
Pinto ShellyVP, Finance and CAODec 29Sale11.074825,33662,097Jan 03 08:52 PM
Randolph SophiaChief Medical OfficerDec 16Option Exercise4.0946,474189,875271,870Dec 20 05:08 PM